Supplementary Material for: Association between microbiome dysbiosis and postoperative disorders before and after gastrectomy by figshare admin karger (2628495)

“…Furthermore, patients experiencing greater weight loss showed a significant reduction in Faecalibacterium prausnitzii levels, while lower serum prealbumin and zinc levels were associated with the abundance of Escherichia coli. …”

Data Sheet 1_Diagnostic utility of hematological and biochemical markers for cystic echinococcosis in Tibetan patients of Sichuan, China.pdf by Meng Ma (2075878)

“…Conversely, there was a decrease in lymphocyte percentage, hemoglobin concentration, mean corpuscular volume, and hematocrit. (2) Prothrombin time levels were markedly elevated beyond normal reference values, with prolonged prothrombin time identified as a significant predictor for CE. (3) The area under the receiver operating characteristic curve (AUC) for predicting CE based on prothrombin time was 0.969, while the AUC for predicting CE using a combination of prothrombin time and eosinophil percentage was 0.982.…”

Data Sheet 1_Can posttreatment blood inflammatory markers predict poor survival in gynecologic cancer?: a systematic review and meta-analysis.xlsx by Minyong Choi (22465405)

“…However, most studies do not report when PBIMs have been sampled, and the ones that do usually use pretreatment levels. Considering their potential to reflect the host immune status, posttreatment PBIMs and their dynamic changes from pretreatment levels may also carry prognostic information. …”

Image 8_Can posttreatment blood inflammatory markers predict poor survival in gynecologic cancer?: a systematic review and meta-analysis.tiff by Minyong Choi (22465405)

“…However, most studies do not report when PBIMs have been sampled, and the ones that do usually use pretreatment levels. Considering their potential to reflect the host immune status, posttreatment PBIMs and their dynamic changes from pretreatment levels may also carry prognostic information. …”

Image 1_Can posttreatment blood inflammatory markers predict poor survival in gynecologic cancer?: a systematic review and meta-analysis.tiff by Minyong Choi (22465405)

“…However, most studies do not report when PBIMs have been sampled, and the ones that do usually use pretreatment levels. Considering their potential to reflect the host immune status, posttreatment PBIMs and their dynamic changes from pretreatment levels may also carry prognostic information. …”

Image 7_Can posttreatment blood inflammatory markers predict poor survival in gynecologic cancer?: a systematic review and meta-analysis.tiff by Minyong Choi (22465405)

“…However, most studies do not report when PBIMs have been sampled, and the ones that do usually use pretreatment levels. Considering their potential to reflect the host immune status, posttreatment PBIMs and their dynamic changes from pretreatment levels may also carry prognostic information. …”

Data Sheet 2_Can posttreatment blood inflammatory markers predict poor survival in gynecologic cancer?: a systematic review and meta-analysis.zip by Minyong Choi (22465405)

“…However, most studies do not report when PBIMs have been sampled, and the ones that do usually use pretreatment levels. Considering their potential to reflect the host immune status, posttreatment PBIMs and their dynamic changes from pretreatment levels may also carry prognostic information. …”

Table 1_Can posttreatment blood inflammatory markers predict poor survival in gynecologic cancer?: a systematic review and meta-analysis.docx by Minyong Choi (22465405)

“…However, most studies do not report when PBIMs have been sampled, and the ones that do usually use pretreatment levels. Considering their potential to reflect the host immune status, posttreatment PBIMs and their dynamic changes from pretreatment levels may also carry prognostic information. …”

Image 4_Can posttreatment blood inflammatory markers predict poor survival in gynecologic cancer?: a systematic review and meta-analysis.tiff by Minyong Choi (22465405)

“…However, most studies do not report when PBIMs have been sampled, and the ones that do usually use pretreatment levels. Considering their potential to reflect the host immune status, posttreatment PBIMs and their dynamic changes from pretreatment levels may also carry prognostic information. …”

Image 3_Can posttreatment blood inflammatory markers predict poor survival in gynecologic cancer?: a systematic review and meta-analysis.tiff by Minyong Choi (22465405)

“…However, most studies do not report when PBIMs have been sampled, and the ones that do usually use pretreatment levels. Considering their potential to reflect the host immune status, posttreatment PBIMs and their dynamic changes from pretreatment levels may also carry prognostic information. …”

Image 2_Can posttreatment blood inflammatory markers predict poor survival in gynecologic cancer?: a systematic review and meta-analysis.tiff by Minyong Choi (22465405)

“…However, most studies do not report when PBIMs have been sampled, and the ones that do usually use pretreatment levels. Considering their potential to reflect the host immune status, posttreatment PBIMs and their dynamic changes from pretreatment levels may also carry prognostic information. …”

Image 5_Can posttreatment blood inflammatory markers predict poor survival in gynecologic cancer?: a systematic review and meta-analysis.tiff by Minyong Choi (22465405)

“…However, most studies do not report when PBIMs have been sampled, and the ones that do usually use pretreatment levels. Considering their potential to reflect the host immune status, posttreatment PBIMs and their dynamic changes from pretreatment levels may also carry prognostic information. …”

Image 6_Can posttreatment blood inflammatory markers predict poor survival in gynecologic cancer?: a systematic review and meta-analysis.tif by Minyong Choi (22465405)

“…However, most studies do not report when PBIMs have been sampled, and the ones that do usually use pretreatment levels. Considering their potential to reflect the host immune status, posttreatment PBIMs and their dynamic changes from pretreatment levels may also carry prognostic information. …”

OVX educes bone density of femur. by Mingzhu Chen (6370013)

“…Compared to Sham rats, OVX tats had a significant decrease in bone mass and impaired bone micro structure: (L) BMD, (M) BV, (N) BV/TV, (O) Tb.N,(P) Tb.Sp, and (Q) Tb.Th. …”

Image 2_Spatial deciphering of the transcriptomic heterogeneity of tumor spread through air spaces in lung cancer.tif by Wenhao Wang (515852)

“…</p>Results<p>Compared with tumor nests in non-STAS patients, HLA-DRB5 and RASGRF1 were significantly less expressed in compartments of STAS, suggesting their inhibitory roles in the occurrence of STAS. …”

Image 4_Spatial deciphering of the transcriptomic heterogeneity of tumor spread through air spaces in lung cancer.tif by Wenhao Wang (515852)

“…</p>Results<p>Compared with tumor nests in non-STAS patients, HLA-DRB5 and RASGRF1 were significantly less expressed in compartments of STAS, suggesting their inhibitory roles in the occurrence of STAS. …”

Data Sheet 1_Spatial deciphering of the transcriptomic heterogeneity of tumor spread through air spaces in lung cancer.zip by Wenhao Wang (515852)

“…</p>Results<p>Compared with tumor nests in non-STAS patients, HLA-DRB5 and RASGRF1 were significantly less expressed in compartments of STAS, suggesting their inhibitory roles in the occurrence of STAS. …”

Image 1_Spatial deciphering of the transcriptomic heterogeneity of tumor spread through air spaces in lung cancer.tif by Wenhao Wang (515852)

“…</p>Results<p>Compared with tumor nests in non-STAS patients, HLA-DRB5 and RASGRF1 were significantly less expressed in compartments of STAS, suggesting their inhibitory roles in the occurrence of STAS. …”

Image 3_Spatial deciphering of the transcriptomic heterogeneity of tumor spread through air spaces in lung cancer.tif by Wenhao Wang (515852)

“…</p>Results<p>Compared with tumor nests in non-STAS patients, HLA-DRB5 and RASGRF1 were significantly less expressed in compartments of STAS, suggesting their inhibitory roles in the occurrence of STAS. …”

Image2_Alhagi maurorum extract in combination with lytic phage cocktails: a promising therapeutic approach against biofilms of multi-drug resistant P. mirabilis.JPEG by Arezoo Mirzaei (11921191)

“…Moreover, in a bladder phantom model, there was a considerable decrease in encrustation levels compared to the control. …”